metyrosine

Generic: metyrosine

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name metyrosine
Generic Name metyrosine
Labeler amneal pharmaceuticals ny llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

metyrosine 250 mg/1

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 69238-1621
Product ID 69238-1621_fe7e12ab-6604-4e78-94c1-e64237cd1289
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213734
Listing Expiration 2026-12-31
Marketing Start 2020-07-24

Pharmacologic Class

Established (EPC)
catecholamine synthesis inhibitor [epc]
Mechanism of Action
catecholamine synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 692381621
Hyphenated Format 69238-1621

Supplemental Identifiers

RxCUI
197980
UPC
0369238162110
UNII
DOQ0J0TPF7
NUI
N0000175569 N0000175361

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name metyrosine (source: ndc)
Generic Name metyrosine (source: ndc)
Application Number ANDA213734 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-1)
  • 30 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-3)
source: ndc

Packages (2)

Ingredients (1)

metyrosine (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "fe7e12ab-6604-4e78-94c1-e64237cd1289", "openfda": {"nui": ["N0000175569", "N0000175361"], "upc": ["0369238162110"], "unii": ["DOQ0J0TPF7"], "rxcui": ["197980"], "spl_set_id": ["027f02b1-be49-4822-91a5-6cd66b56c0e1"], "pharm_class_epc": ["Catecholamine Synthesis Inhibitor [EPC]"], "pharm_class_moa": ["Catecholamine Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-1)", "package_ndc": "69238-1621-1", "marketing_start_date": "20200724"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-3)", "package_ndc": "69238-1621-3", "marketing_start_date": "20201215"}], "brand_name": "metyrosine", "product_id": "69238-1621_fe7e12ab-6604-4e78-94c1-e64237cd1289", "dosage_form": "CAPSULE", "pharm_class": ["Catecholamine Synthesis Inhibitor [EPC]", "Catecholamine Synthesis Inhibitors [MoA]"], "product_ndc": "69238-1621", "generic_name": "metyrosine", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "metyrosine", "active_ingredients": [{"name": "METYROSINE", "strength": "250 mg/1"}], "application_number": "ANDA213734", "marketing_category": "ANDA", "marketing_start_date": "20200724", "listing_expiration_date": "20261231"}